Systemic inflammation and innate immune response in patients with previous anterior uveitis

British Journal of Ophthalmology

Volumn 86, Issue 4, 2002, Pages 412-417

  Huhtinen, Minna ^a   Repo, H ^b   Laasila, K ^c   Jansson, S E ^d   Kautiainen, H ^e   Karma, A ^a   Leirisalo Repo, M ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Department of Bacteriology and Immunology   (Finland)

^c Division of Rheumatology   (Finland)

^d Department of Clinical Chemistry ^*  (Finland)

^e RHEUMATISM FOUNDATION HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; INTERLEUKIN 2 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BLOOD CULTURE; CHEMOLUMINESCENCE; CONTROLLED STUDY; EYE INFLAMMATION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; INFLAMMATION; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIGENS, CD14; C-REACTIVE PROTEIN; CELL COUNT; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MALE; MONOCYTES; RECEPTORS, IGG; RECEPTORS, INTERLEUKIN-2; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS, ANTERIOR;

EID: 0036219907     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.86.4.412     Document Type: Article

References (40)

1. International uveitis study group recommendations for the evaluation of intraocular inflammatory disease
2. Acute anterior uveitis and spondyloarthropathies
3. Endotoxin-induced uveitis in rats as a model for human disease
4. Interleukin-2 receptor membrane in bound and soluble form in the aqueous humor and peripheral blood of patients with acute untreated uveitis
5. Levels of soluble ICAM-1 and soluble IL-2R in the serum and aqueous humor of uveitis patients
6. Aqueous and serum interferon ç, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis
7. Recognition of gram-negative bacteria and endotoxin by the innate immune system
8. Activation of human monocyte functions by tumor necrosis factor: Rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release
9. + subpopulation
10. ++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics
11. + blood monocytes is expanded in sepsis patients
12. Correlations of monocyte phagocytic receptor expressions with serum immune complex level in systemic lupus erythematosus
13. Differential cytokine expression in human blood monocyte subpopulations: A polymerase chain reaction analysis
14. Does innate immune privilege exist?
15. Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro
16. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages
17. Markers of systemic inflammation predicting organ failure in community-acquired septic shock
18. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor [alpha] expression in macrophages by inducing apoptosis
19. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells
20. In vitro effect of gold sodium thiomalate and methotrexate on tumor necrosis factor production in normal healthy individuals and patients with rheumatoid arthritis
21. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy
22. Flow cytometric determination of CD11b upregulation in vivo
23. Binding of human peripheral blood polymorphonuclear leukocytes to E-selcectin (CD62E) does not promote their activation
24. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes
25. Production of tumor necrosis factor and interleukin 1 by monocytes of patients with previous Yersinia arthritis
26. Peripheral blood monocytes from patients with reactive arthritis show normal production of tumor necrosis factor-alpha
27. Endotoxin-induced uveitis in the rat: Observations on altereed vascular permeability, clinical findings, and histology
28. IL-6 antagonizes TGF-β and abolishes immune privilege in eyes with endotoxin-induced uveitis
29. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: An inherited defect in mucosal defence
30. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation
31. Relevance of the tumor necrosis factor α (TNF α)-308 promoter polymorphism in TNF α gene regulation
32. 308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter
33. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction: Possible implications for leucocyte aggregation and microvascular plugging
34. C(-260)-T polymorphism in the promoter of the CD14 molecule receptor gene as a risk factor for myocardial infarction
35. Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men
36. Expression of arthritis-causing HLA-B27 on Hela cells promotes induction of c-fos in response to in vitro invasion by Salmonella typhimurium
37. Infections, inflammation, and the risk of coronary heart disease
38. High frequency of silent inflammatory bowel disease in spondylarthropathy
39. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock
40. Endotoxin down-regulates T cell activation by antigen-presenting liver sinusoidal endothelial cells